The ability of estrogen to shield the brain from the bio-energetic insult, hypoglycemia, is unclear. Estradiol prevents hypoglycemic activation of the energy deficit sensor, adenosine 5′-monophosphate-activated protein kinase (AMPK), in hindbrain metabolo-sensory A2 noradrenergic neurons. Here, we investigated the hypothesis that estrogen regulates A2 AMPK through control of fuel metabolism and/or upstream protein kinase/phosphatase enzyme expression. A2 cells were harvested by laser-microdissection after insulin (INS) or vehicle (V) injection of estradiol (E)- or oil (O)-implanted ovariectomized female rats. Cell lysates were evaluated by immunoblot for glycolytic, tricarboxylic acid cycle (TCA), respiratory chain, and acetyl CoA-malonyl CoA pathway enzymes. A2 phosphofructokinase (PFKL), isocitrate dehydrogenase, and pyruvate dehydrogenase and ATP synthase subunit profiles were elevated in E/V versus O/V; hypoglycemia augmented PFKL and alpha-ketoglutarate dehydrogenase expression in E only. Hypoglycemia increased A2 Ca++/calmodulin-dependent protein kinase-beta in O, while reducing PP2A in both groups. A2 phosphoAMPK levels were equivalent in O/V versus E/V, but elevated during hypoglycemia in O only. These results implicate estradiol in compensatory up-regulation of substrate catabolism and corresponding maintenance of energy stability of A2 metabolo-sensory neurons during hypoglycemia, outcomes that support the potential viability of molecular substrates for hormone action as targets for therapies alleviating hypoglycemic brain injury.